Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Yang

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 7, 2023
[Effect and safety of 10-day decitabine-containing conditioning regimen for allogeneic hematopoietic stem cell transplantation in 31 patients with acute myeloid leukemia/myelodysplastic syndrome]J Liu, Y G Cao, R L Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 16, 2020
[Comparison of autologous versus matched sibling donor stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia]M N Lyu, E L Jiang, Y He, et al.
Zhonghua Yi Xue Za Zhi|November 29, 2023
[Efficacy and safety of allogeneic hematopoietic stem cell transplantation for the treatment of primary myelofibrosis]J L Wang, H X Zhang, J L Wei, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 26, 2010
Risk factors and prognosis of invasive fungal infections in allogeneic stem cell transplantation recipients: a single-institution experienceP Zhang, E-L Jiang, D-L Yang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 22, 2018
[Effects of preexisting donor-specific HLA antibodies for graft failure in un-manipulated haploidentical hematopoietic stem cell transplantation]R L Zhang, X H Zheng, L K Zhou, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 18, 2020
[Clinical features and risk factors analyses of patients with T cell large granular lymphocytosis following allo-HSCT]F Zhao, Y Y Shi, G X Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 26, 2019
[Outcomes and prognostic factors of myelodysplastic syndrome patients with allogeneic hematopoietic stem cell transplantation]Z X Liu, M N Lyu, Q Q Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 25, 2023
[Survival efficacy of MDS/AML patients with TP53 abnormal received allogeneic hematopoietic stem cell transplantation]D Feng, M Y Wang, J Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 25, 2018
[Allogeneic hematopoietic stem cell transplantation for treatment of refractory and relapsed acute myeloid leukemia: outcomes and prognostic factors]X H Su, J F Yao, G X Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 3, 2025
[Identifying risk factors for acute graft-versus-host disease in patients with acute myeloid leukemia undergoing haploidentical hematopoietic stem cell transplantation]D Feng, W Liang, J X Cao, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 7, 2023
[Effect and safety of 10-day decitabine-containing conditioning regimen for allogeneic hematopoietic stem cell transplantation in 31 patients with acute myeloid leukemia/myelodysplastic syndrome]J Liu, Y G Cao, R L Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 16, 2020
[Comparison of autologous versus matched sibling donor stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia]M N Lyu, E L Jiang, Y He, et al.
Zhonghua Yi Xue Za Zhi|November 29, 2023
[Efficacy and safety of allogeneic hematopoietic stem cell transplantation for the treatment of primary myelofibrosis]J L Wang, H X Zhang, J L Wei, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 26, 2010
Risk factors and prognosis of invasive fungal infections in allogeneic stem cell transplantation recipients: a single-institution experienceP Zhang, E-L Jiang, D-L Yang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 22, 2018
[Effects of preexisting donor-specific HLA antibodies for graft failure in un-manipulated haploidentical hematopoietic stem cell transplantation]R L Zhang, X H Zheng, L K Zhou, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 18, 2020
[Clinical features and risk factors analyses of patients with T cell large granular lymphocytosis following allo-HSCT]F Zhao, Y Y Shi, G X Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 26, 2019
[Outcomes and prognostic factors of myelodysplastic syndrome patients with allogeneic hematopoietic stem cell transplantation]Z X Liu, M N Lyu, Q Q Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 25, 2023
[Survival efficacy of MDS/AML patients with TP53 abnormal received allogeneic hematopoietic stem cell transplantation]D Feng, M Y Wang, J Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 25, 2018
[Allogeneic hematopoietic stem cell transplantation for treatment of refractory and relapsed acute myeloid leukemia: outcomes and prognostic factors]X H Su, J F Yao, G X Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 3, 2025
[Identifying risk factors for acute graft-versus-host disease in patients with acute myeloid leukemia undergoing haploidentical hematopoietic stem cell transplantation]D Feng, W Liang, J X Cao, et al.
Pageof 9